Medifast (MED) Tops Q3 EPS by 6c; Boosts FY16 Outlook

November 4, 2016 8:41 AM EDT

Find out which companies are about to raise their dividend well before the news hits the Street with's Dividend Insider Elite. Sign-up for a FREE trial here.

Medifast (NYSE: MED) reported Q3 EPS of $0.51, $0.06 better than the analyst estimate of $0.45. Revenue for the quarter came in at $68.6 versus the consensus estimate of $66.79 million.


Medifast sees Q4 2016 EPS of $0.30-$0.33. Medifast sees Q4 2016 revenue of $63-66 million.

Medifast sees FY2016 EPS of $1.86-$1.89, versus prior guidance of $1.79-$1.84 and the consensus of $1.88. Medifast sees FY2016 revenue of $275-278 million, versus the consensus of $275.6 million.

For earnings history and earnings-related data on Medifast (MED) click here.

Serious News for Serious Traders! Try Premium Free!

You May Also Be Interested In

Related Categories

Earnings, Guidance, Hot Guidance

Related Entities


Add Your Comment